Originally published by our sister publication Infectious Disease Special Edition
By Meaghan Lee Callaghan
The new members of the revamped Advisory Committee on Immunization Practices, in a vote of 5-1-1, recommended removing the preservative thimerosal from the few remaining influenza vaccine formulations that still include it. It will come into effect for the 2025-2026 flu season.
The recommendation came as three separate votes focused on three groups—children, pregnant people and